Sales of Biohaven's migraine tablet exceed expectations
![Photo: Kåre Viemose](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13118295.ece/ALTERNATES/schema-16_9/doc7gkaq2d94exb2104fss.jpg)
After Biohaven's migraine drug Nurtec ODT was approved for preventative treatment of episodic migraines in addition to its previous approval as an acute treatment, sales have exploded.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
FDA approves migraine pill as preventative treatment
For subscribers